Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yuanqiang Jiang"'
Publikováno v:
Biochemical and Biophysical Research Communications. 470:324-330
Mammalian target of rapamycin (mTOR) as a potential drug target for treatment of acute myeloid leukemia (AML). Here, we investigated the potential anti-leukemic activity by WYE-687, a potent mTOR kinase inhibitor. We demonstrated that WYE-687 potentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f784b73f6ef5e35106fe49034ef6f6
https://doi.org/10.1016/j.bbrc.2016.01.054
https://doi.org/10.1016/j.bbrc.2016.01.054
Autor:
Xin Zhou, Feng Cheng, Yuanxin Zhu, Jingjue Mao, Hongfeng Guo, Jing Wang, Yuanqiang Jiang, Heng Chen
Publikováno v:
Experimental and Therapeutic Medicine
Studies have shown that the bortezomib-based retreatment of patients with multiple myeloma (MM) may prolong control of the disease. The optimal duration of bortezomib-based retreatment in relapsed or refractory MM is unknown. The present retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a992ecf8ba7b68c897853da0e48d7b
http://europepmc.org/articles/PMC3964925
http://europepmc.org/articles/PMC3964925
Publikováno v:
British Journal of Biomedical Science. 66:20-24
Expression of the CDH13 gene in chronic myeloid leukaemia (CML) patients at different clinical stages, and its relationship with the BCR/ABL fusion gene, is investigated. Expression of the CDH13 gene and the BCR/ABL fuse gene is investigated in perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d505eac9e04d86599173f742e57fef
https://doi.org/10.1080/09674845.2009.11730239
https://doi.org/10.1080/09674845.2009.11730239
Publikováno v:
Cell biochemistry and biophysics. 72(1)
We sought to determine the expression levels of hypoxia-inducible factor-1α (HIF-1α) in the bone marrow chronic myelogenous leukemia (CML) patients. We also tried to determine the roles HIF-1α in the proliferation of CML cells by small interfering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a37ba124cceeb8fdf759673fc9c248e
https://pubmed.ncbi.nlm.nih.gov/25596666
https://pubmed.ncbi.nlm.nih.gov/25596666
Autor:
Xifeng Qian, Xin Zhou, Jun Xia, Hong-Li Sun, Feng Chen, Yuanqiang Jiang, Mize Lu, Heng Chen, Yun-Feng Shen, Jingjue Mao, Yun Zhuang, Guohua Yang, Chao Sun, Hongfeng Guo
Publikováno v:
American Journal of Hematology. 85:499-501
Bortezomib has proven to be active in patients with multiple myeloma (MM), including elderly patients. The aim of this study was to evaluate the efficacy and toxicity of bortezomib in combination with intermediate-dose dexamethasone (Dex) and thalido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf87c72932a2dc1572f46dd8967424b4
https://doi.org/10.1002/ajh.21734
https://doi.org/10.1002/ajh.21734
JAK2 V617F, MPL W515L and JAK2 exon 12 mutations are novel acquired mutations that induce constitutive cytokine-independent activation of the JAK-STAT pathway in myeloproliferative disorders (MPD). The discovery of these mutations provides novel mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a12a11d403e52eff0b015742e967d4d
https://europepmc.org/articles/PMC3555257/
https://europepmc.org/articles/PMC3555257/
Autor:
Yu, Zhu, Wei, Xu, Qiong, Liu, Jinlan, Pan, Hairong, Qiu, Rong, Wang, Chun, Qiao, Yuanqiang, Jiang, Sujiang, Zhang, Lei, Fan, Jianfu, Zhang, Yunfeng, Shen, Yongquan, Xue, Jianyong, Li
Publikováno v:
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics. 25(5)
To investigate the characteristics of the abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities (CCAs).Abnormalities of chromosome 17 were analyzed in 73 patients with myeloid malignancies with CCAs showed by R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14a297786f57f4e6c1950d12cff4ca18
https://pubmed.ncbi.nlm.nih.gov/18841577
https://pubmed.ncbi.nlm.nih.gov/18841577
Autor:
Si-Xuan Qian, Wei Xu, Jianyong Li, Han-Xin Wu, Hua Lu, Yuanqiang Jiang, Tian Tian, Su-Jiang Zhang, Yunfeng Shen
Publikováno v:
Leukemia research. 31(10)
The aim of this study was to evaluate the efficacy and toxicity of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (G-CSF) protocol in elderly patients with acute myeloid leukemia (AML). A total of 50 eld
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bf4d48212a7b4f335ec29eea57b563
https://pubmed.ncbi.nlm.nih.gov/17420048
https://pubmed.ncbi.nlm.nih.gov/17420048
Publikováno v:
Farmacia; Mar/Apr2017, Vol. 65 Issue 2, p241-246, 6p
Autor:
JINGJUE MAO, FENG CHENG, HENG CHEN, JING WANG, XIN ZHOU, YUANQIANG JIANG, YUANXIN ZHU, HONGFENG GUO
Publikováno v:
Experimental & Therapeutic Medicine; 2014, Vol. 7 Issue 4, p977-981, 5p